Fulton Bank N.A. Increases Stock Holdings in CVS Health Co. (NYSE:CVS)

Fulton Bank N.A. boosted its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 13.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,803 shares of the pharmacy operator's stock after acquiring an additional 4,613 shares during the quarter. Fulton Bank N.A.'s holdings in CVS Health were worth $2,561,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Whitebox Advisors LLC purchased a new position in shares of CVS Health in the fourth quarter valued at $249,000. B&D White Capital Company LLC purchased a new position in shares of CVS Health in the fourth quarter valued at $417,000. Fairfax Financial Holdings Ltd. Can purchased a new position in shares of CVS Health in the fourth quarter valued at $121,742,000. Lazard Asset Management LLC increased its position in shares of CVS Health by 7.3% in the fourth quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock valued at $192,617,000 after buying an additional 293,406 shares in the last quarter. Finally, Seizert Capital Partners LLC boosted its stake in shares of CVS Health by 22.8% during the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after acquiring an additional 105,708 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Mizuho increased their price objective on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Barclays decreased their price objective on CVS Health from $82.00 to $79.00 and set an "overweight" rating on the stock in a research note on Monday. Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Finally, Piper Sandler increased their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Two investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Trading Down 0.0%

Shares of NYSE CVS traded down $0.03 during midday trading on Wednesday, hitting $63.56. The stock had a trading volume of 5,852,394 shares, compared to its average volume of 11,131,533. The company has a market capitalization of $80.40 billion, a price-to-earnings ratio of 17.37, a PEG ratio of 0.98 and a beta of 0.60. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The company has a fifty day moving average price of $65.47 and a 200 day moving average price of $59.77.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company's revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 EPS. On average, analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.19%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.